Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement


Gretchen Stevens and colleagues present the GATHER statement, which seeks to promote good practice in the reporting of global health estimates.


Vyšlo v časopise: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. PLoS Med 13(6): e32767. doi:10.1371/journal.pmed.1002056
Kategorie: Guidelines and Guidance
prolekare.web.journal.doi_sk: 10.1371/journal.pmed.1002056

Souhrn

Gretchen Stevens and colleagues present the GATHER statement, which seeks to promote good practice in the reporting of global health estimates.


Zdroje

1. Graham WJ, Adjei S (2010) A call for responsible estimation of global health. PLoS Med 7: e1001003. doi: 10.1371/journal.pmed.1001003 21151346

2. Boerma T, Mathers CD (2015) The World Health Organization and global health estimates: improving collaboration and capacity. BMC Med 13: 50. doi: 10.1186/s12916-015-0286-7 25858025

3. Hambleton IR, Howitt C, Rose AM, Samuels TA, Unwin N (2015) Global trends in dietary quality. Lancet Glob Health 3: e593. doi: 10.1016/S2214-109X(15)00082-0 26385296

4. Byass P (2010) The imperfect world of global health estimates. PLoS Med 7: e1001006. doi: 10.1371/journal.pmed.1001006 21152416

5. Walker N, Bryce J, Black RE (2007) Interpreting health statistics for policymaking: the story behind the headlines. Lancet 369: 956–963. 17368157

6. Murray CJ (2007) Towards good practice for health statistics: lessons from the Millennium Development Goal health indicators. Lancet 369: 862–873. 17350457

7. Atun R (2014) Time for a revolution in reporting of global health data. Lancet. 384: 937–938. doi: 10.1016/S0140-6736(14)61062-X 25059946

8. World Health Organization (2013) Global Health Estimates: Proposals on the way forward. Summary of a Technical Meeting, WHO, Geneva, 13–14 February 2013.: World Health Organization.

9. Moher D, Schulz KF, Simera I, Altman DG (2010) Guidance for developers of health research reporting guidelines. PLoS Med 7: e1000217. doi: 10.1371/journal.pmed.1000217 20169112

10. Altman DG, Simera I, Hoey J, Moher D, Schulz K (2008) EQUATOR: reporting guidelines for health research. Lancet 371: 1149–1150. doi: 10.1016/S0140-6736(08)60505-X 18395566

11. Garnett GP, Cousens S, Hallett TB, Steketee R, Walker N (2011) Mathematical models in the evaluation of health programmes. Lancet 378: 515–525. doi: 10.1016/S0140-6736(10)61505-X 21481448

12. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097. doi: 10.1371/journal.pmed.1000097 19621072

13. Lang TA, Altman DG (2013) Basic statistical reporting for articles published in clinical medical journals: the SAMPL Guidelines. In: Smart P, Maisonneuve H, editors. Science Editors' Handbook: European Association of Science Editors.

14. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, et al. (2012) Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force—7. Value Health 15: 843–850. doi: 10.1016/j.jval.2012.04.012 22999134

15. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, et al. (2013) Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 16: 231–250. doi: 10.1016/j.jval.2013.02.002 23538175

16. Boerma JT, Mathers C, Abou-Zahr C (2010) WHO and global health monitoring: the way forward. PLoS Med 7: e1000373. doi: 10.1371/journal.pmed.1000373 21151348

17. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ 85: 867–872. 18038077

18. Schulz KF, Altman DG, Moher D, Group C (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 7: e1000251. doi: 10.1371/journal.pmed.1000251 20352064

19. World Health Organization (2014) Global Reference List of 100 Core Health Indicators: Working Version 5. Geneva: World Health Organization. 20 p.

20. Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, et al. (2014) Reducing waste from incomplete or unusable reports of biomedical research. Lancet 383: 267–276. doi: 10.1016/S0140-6736(13)62228-X 24411647

21. Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, et al. (2014) Increasing value and reducing waste: addressing inaccessible research. Lancet 383: 257–266. doi: 10.1016/S0140-6736(13)62296-5 24411650

22. Walport M, Brest P. (2011) Sharing research data to improve public health. Lancet 377: 537–539. doi: 10.1016/S0140-6736(10)62234-9 21216456

23. Bill & Melinda Gates Foundation (2015) Bill & Melinda Gates Foundation Open Access Policy. Bill & Melinda Gates Foundation. http://www.gatesfoundation.org/how-wework/general-information/open-access-policy. Accessed March 18, 2015.

24. Bloom T, Ganley E, Winker M (2013) Data access for the open access literature: PLOS’s data policy. Dec 12, 2013. http://www.plos.org/data-access-for-the-open-access-literature-ploss-data-policy/. Accessed March 18, 2015.

25. Nature Publishing Group (2014) Availability of data, materials and methods. Nature Publishing Group. http://www.nature.com/authors/policies/availability.html. Accessed March 18, 2015.

26. Murray CJ, Frenk J (2008) Health metrics and evaluation: strengthening the science. Lancet 371: 1191–1199. doi: 10.1016/S0140-6736(08)60526-7 18395581

27. Mathers CD, Salomon JA, Ezzati M, Begg S, Vander Hoorn S, et al. (2006) Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. Global burden of disease and risk factors. New York: Oxford University Press. pp. 399–426.

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2016 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Hereditární TTR amyloidóza – vzácné, nebo jen neodhalené onemocnění? 2. díl
nový kurz

Eozinofilní granulomatóza s polyangiitidou

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa